Introduction
Changes in the biological characteristics of HIV-l from peripheral blood leucocytes (PBL) have been well documented. It has been suggested that changes with time in the biological features of HIV are signs of increased virulence. Attempts have been made to link replication potential and the cytopathic syncytiainducing properties of HIV isolates with the clinical status and severity of HIV infection in the host. Despite the fact that HIV has been isolated from the lung, little is known about the properties of these isolates in contrast to isolates derived from PBL. We report the changing nature of HIV infection in the lung in a patient following the successful treatment of Pneumocystis carinii pneumonia (PCP). Pulmonary HIV infection, but not HIV isolated from PBL, evolved to become syncytium-inducing within 3 months. This may have important implications regarding the pathogenesis of HIV disease. Report HIV-l strains vary remarkably in their cellular tropism and a multitude of phenotypic variants exist (1). The replication capacity of HIV falls into two broad designations, viruses that grow rapidly to high titre ('rapid/high') and those that replicate slowly with only small amounts of virus recoverable ('slow/ low'). It has been suggested that the progression to AIDS in infected individuals correlates with the emergence of 'rapid/high' HIV variants, resulting in decreased CD4 cell counts (1,2) and that changes in the biological features of HIV in vitro with time are signs of increased virulence of HIV to the host.
HIV has been detected in the lungs of AIDS patients (3) by a number of methods including the detection of reverse transcriptase (3), P24 antigens (3) and HIV proviral DNA (3) in alveolar macrophages. In addition, viral RNA transcripts have been found in lung tissue from AIDS patients with pulmonary infection (4) and HIV has been isolated from bronchoalveolar lavage (BAL) from individuals with pulmonary disease (3). However, despite the fact that HIV has been isolated from the lung, little is known about the biological or molecular properties of these isolates in contrast to isolates derived from PBL.
We report rapid changes in HIV isolates obtained from the lung sequentially from a single patient. A 27-year-old male presented with 2 months of weight loss of 1.5 stone, shortness of breath and a dry cough. His HIV status was confirmed at the time of bronchoscopy.
Chest X-ray showed changes typical of PCP and this was confirmed cytologically at bronchoscopy.
He received a 3-week course of co-trimoxazole (20 mg kg -' day -' trimethoprim; lOOmgkg-'day-' sulphamethoxazole) but he remained unwell with fever. A second bronchoscopy was done 2 weeks later to exclude a second pathogen. All cultures were negative but the patient responded to a combination of erythromycin and ciprofloxacin. Two months later, he complained of a 2-week history of increasing shortness of breath with cough productive of mucoid sputum. He was febrile and widespread crackles were audible. The chest X-ray on this occasion was normal but the carbon monoxide transfer factor (TLCO) was reduced to 51% of predicted normal, indicating the presence of a pulmonary abnormality.
A third bronchoscopy was undertaken but no specific pathogen was detected in the BAL, and transbronchial lung biopsies showed normal lung tissue only (Table 1) . He responded to broad spectrum antibiotics, although his respiratory crackles persisted.
The patient subsequently developed both CMV retinitis and colitis which were treated successfully with ganciclovir (Table 2) . He continued to suffer from dyspnoea, occasional fevers and audible J. R. Clarke et al. Virus isolation was carried out on all four paired PBL and BAL samples in the following way: 2 x lo6 of either PBL or BAL cells were stimulated with 1 pg ml-' of phytohaemagglutinin (PHA) and 100 units ml ~ ' of interleukin-2 (IL-2), and then co-cultivated with 1 x lo6 cord blood leucocytes (CBL) that had been stimulated for 3 days with 1 pug ml -' PHA prior to use. The results of the laboratory investigations are shown in Table 1 . In the first and second matched PBL and BAL samples, no viral induced syncytial cytopathic effect was visible by microscopic examination of the co-cultivation cultures. P24 antigen was detected in the PBL and BAL cell culture supernatants from the ninth and sixteenth day of culture respectively. P24 antigen was also detected in the PBL and BAL cultures of the second matched pair at 2 days in both samples. In the third matched PBL and BAL samples, P24 antigen was detectable in the supernatant from the BAL culture after 18 h. Large syncytia were also visible microscopically in the BAL cell culture at 2 days and developed to engulf most of the culture by 6 days post-infection.
P24 antigen was detected in culture supernatant of both the fourth PBL and BAL matched samples by 24 h post-infection.
In both instances, this was accompanied by pronounced syncytia which were observed in both cultures by 2 days post-infection.
Polymerase chain reaction analysis of the PBL and BAL cells from this patient was undertaken using quantitative methodology (5). In the initial PBL and BAL samples, about 100 copies of HIV proviral DNA were detected/lo6 cells. In the second matched sample, taken 2 weeks after the first, a IO-fold increase in the amount of recoverable HIV proviral DNA was detectable in both samples. However, in the third pair of matched PBL and BAL samples, taken 10 weeks later, the number of HIV proviral DNA copies detected in lo6 PBL cells was 1000 but had risen to 10 000 copies detectable from lo6 BAL cells. A limiting cell dilution quantitative PCR analysis was also undertaken on the third matched PBL and BAL sample, in which a series of IO-fold dilutions of PBL and BAL cells was also made for PCR examination to determine the number of cells in which HIV was detectable. Interestingly, the number of cells where HIV was detected by PCR from the PBL was 100, or 1: 10 000 cells, whilst HIV proviral DNA was detected in 10 000 BAL, or 1: 100 cells.
Viral tropism of HIV isolates from BAL and PBL at the time of the fourth bronchoscopy differed. In both these cell lines, isolates from BAL grew in CEM, H9, and MOLT-4 lymphoblastoid cell lines and HL-60, and U937 monoblastoid cell lines in addition to CBL primary cells producing syncytia in all cell lines, whereas the matched PBL showed restricted tropism and grew in CEM lymphoblastoid cells and CBL only but did produce syncytia. Bronchoalveolar lavage and PBL strains could not be distinguished by replication kinetics in CBL. In this respect, we have used CBL as a readily available source of peripheral blood mononuclear cells (PBMC).
Most studies describing the cytopathic properties of HIV-l strains have relied upon growth of virus in continuous cell lines such as MT-2 (1). Most non-syncytium-inducing (NSI) strains of HIV-l do not, however, grow in MT-2 cells. It is well established that the growth of many clinical isolates of HIV-l is highly restricted to PBMC which are considered to be susceptible target cells for all variants of HIV-l (6). Indeed, HIV-l is not only capable of growth in PBMC but many strains can also cause syncytium formation.
We have previously shown that the biological phenotype of HIV-l isolated from the lung of AIDS patients can be distinguished in all instances from the corresponding strain isolated simultaneously from the peripheral blood (7). Indeed, others have found genotypic variation in the third (V3) and fourth (V4) hypervariable regions of the envelope gene of HIV strains obtained simultaneously from peripheral blood monocytes and alveolar macrophages (8). The extent of genetic variation within the V4 region was particularly striking and strongly suggests HIV may be evolving separately in the lung compared to in the peripheral blood.
Biological and genetic heterogeneity of HIV-l isolates derived from PBL have been extensively studied (1,2). HIV-l strains exhibit differences in nucleotide sequences, neutralization by panels of antibodies, cell tropism and cytopathic effects (9, review). Even though HIV-l has been isolated from the lung of AIDS patients, little is known about the biological or molecular properties of these isolates. This is surprising as opportunistic infections of the lung are important causes of morbidity and mortality in AIDS patients, and the diagnosis of PCP in HIV-l infected individuals is one of the most common AIDS defining diagnoses.
Previously, we have shown that an episode of PCP does not predispose to HIV-l infection of BAL lung macrophages or lymphocytes nor, conversely, does HIV-l infection of these lung cells predispose individuals to PCP (10). We have also shown previously that HIV-l can be detected by PCR in the BAL cells of 65% of AIDS patients (11). This report shows that HIV infection of the lung may change rapidly during PCP following successful treatment. From molecular studies of HIV, it is known that cellular factors stimulate the transcription of HIV RNA and upregulate the production of HIV progeny. Therefore, it is tempting to speculate that the changes observed in the lung of this patient were due to the stimulation of virus infected cells by the opportunist pathogen. However, virus from the first BAL sample when PCP was present took 16 days to detect and was nonsyncytiotropic, yet virus from the third BAL was isolated in 18 h and was highly syncytiotropic.
At this stage, the patient had recovered fully from PCP (negative bronchoscopy) yet had persistent respiratory symptoms of cough and breathlessness and abnormal lung function tests. Lung function following an episode of PCP may remain abnormal despite resolution of the pneumonia. The role of HIV per se in the development of this patient's persistent respiratory symptoms and abnormal lung function is unclear but raises interesting questions.
Of further interest is the comparison between the PBL and BAL virus from this patient. In the first sample, virus was detectable by P24 antigen assay in the PBL by 9 days and the BAL at 16 days. In the second sample, virus was detectable in both samples by 2 days post-co-cultivation, whilst in the third BAL sample, virus was syncytia forming and could be detected overnight.
This may be due to differences in the number of infected alveolar cells with replicating HIV recovered by bronchoscopy. However, quantitative PCR analysis and changes from non-cytopathic to syncytia-inducing virus indicates a rapidly evolving virus infection of the lung, possibly as a consequence of opportunist pneumonia. What is of particular interest is that high yield syncytia-inducing virus emerged from the lung in the third bronchoscopy sample and could possibly be a source of further infection of HIV to PBL trafficking through the lung. Finally, the tropism of viruses obtained from PBL and BAL at the fourth bronchoscopy differed, with the BAL virus isolate showing a greater range of tropism than the PBL virus.
